The Weekly Litigation News Digest is now live. Subscribe now

Outlook Therapeutics competitive analysis

Loading summary...

Explore Outlook Therapeutics's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 13, 2025
Patent NumberPublication DateTitleTotal Oppositions
Jul 22, 2020Modulation Of Afucosylated Species In A Monoclonal Antibody Composition1

Latest PTAB cases involving Outlook Therapeutics

Discover the latest PTAB cases involving Outlook Therapeutics, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Outlook Therapeutics with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 13, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
OUTLOOK THERAPEUTICS - 1 - -
PATENTANWALTE ISENBRUCK BOSL HORSCHLER PARTG MBB18 - - -